Access with Evidence Development in the UK: Past Experience, Current Initiatives and Future Potential

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.28, Iss.2, 2010-02, pp. : 163-170

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Access with Evidence Development: The US Experience

By Mohr Penny E. Tunis Sean R.

PharmacoEconomics, Vol. 28, Iss. 2, 2010-02 ,pp. : 153-162

Adis International

Access to resources Recommend Favorite

Editorial (Thematic Issue: Gene Therapy for Gastrointestinal and Liver Cancers: Past Experience, Current Status and Future Perspectives)

Current Gene Therapy, Vol. 15, Iss. 2, 2015-04 ,pp. : 93-96

Bentham Science Publishers

Access to resources Recommend Favorite

Immunoconjugates: Current Status and Future Potential

By Eaton M.

Journal of Drug Targeting, Vol. 10, Iss. 7, 2002-01 ,pp. : 525-527

Informa Healthcare

Access to resources Recommend Favorite

Microdosing and drug development: past, present and future

By Lappin Graham

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 7, 2013-07 ,pp. : 817-834

Informa Healthcare

Access to resources Recommend Favorite